IP Library › Granted Patent US 10,493,020
Granted Patent B2
US 10,493,020 · App. 15/099,120 · Granted Dec 3, 2019

Method of improving the appearance of periorbital dyschromia

Inventor: Karen Marie Osorio (Cincinnati, OH)
Assignee: The Procter & Gamble Company
A61K8/97A61K8/062A61K8/37A61K8/42A61K8/498A61K8/602A61K8/9789A61K36/21A61K36/42A61K36/48A61Q19/005A61Q19/02A61Q19/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,493,020
App. No.
15/099,120
Granted
Dec 3, 2019
Kind
B2
Abstract

A method of improving the appearance of periorbital dyschromia by identifying a target portion of skin in the periorbital region of a person that exhibits periorbital dyschromia and applying a personal care composition to the target portion of skin during a treatment period. The personal care composition includes an effective amount of Type I active, an effective amount of a Type II active, and a dermatologically acceptable carrier. The treatment period is of sufficient length for at least one of the actives to improve the appearance of the periorbital dyschromia.

Claims (9)

1. A method of improving the appearance of periorbital dyschromia, comprising:

a. identifying a target portion of skin exhibiting periorbital dyschromia, wherein the target portion of skin is disposed in Zones 1 and 3 of a periorbital region of a user and includes brown, orange, and yellow tones; and

b. applying a personal care composition to the target portion of skin during a treatment period, wherein the personal care composition comprises an effective amount of a Type I active, an effective amount of a Type II active, a dermatologically acceptable carrier, and a viscosity of about 50,000 to about 200,000 centipoise, and the treatment period is sufficient for the composition to improve the appearance of the periorbital dyschromia.

2. The method of claim 1 , wherein the Type I active includes a mixture of propyl gallate, gallyl glucoside, and epigallocatechin gallatyl glucoside, a mixture of Chenopodium quina seed extract and butylene glycol, or a combination of these.

3. The method of claim 1 , wherein the Type II active includes an extract of Vicia faba , an extract of Cucurbita pepo , cholecalciferol, or a combination of these.

4. The method of claim 1 , wherein the Type I and Type II actives are each present at an amount of about 0.0001 wt % to about 5 wt %.

5. The method of claim 1 , wherein the improvement in appearance of the periorbital dyschromia corresponds to a positive change in Visual Perception Scale score.

6. The method of claim 1 , wherein the improvement in appearance of the periorbital dyschromia corresponds to a decrease in blood perfusion.

7. The method of claim 1 , wherein the improvement in appearance of the periorbital dyschromia corresponds to an increase in L* value, a decrease in a* value, an increase in b* value or a combination of these.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2016
From: OSORIO, KAREN MARIE
To: THE PROCTER & GAMBLE COMPANY
Reel/Frame 040114/0089 →
Continuity (1)
Related Publication 20170296461A1 · Oct 19, 2017